Leonard R. Prosnitz, MD
This content is PDF only. Please click on the PDF icon to access.
To the Editors: The report by Johnson and colleagues (1) on the role of thoracic radiotherapy in carcinoma of the lung in a recent issue has a provocative title; I do not believe, however, that the data justify such an unqualified conclusion.
The second sentence in the Discussion is the heart of the problem. The primary argument for using curative radiotherapy in unresectable lung cancer is indeed the prospect that occasional cures can be achieved. Long-term survivals from 5% to 7% have been reported in a number of retrospective series (2). If that is the hypothesis that we are testing
Prosnitz LR. Radiotherapy for Lung Cancer. Ann Intern Med. ;114:95–96. doi: 10.7326/0003-4819-114-1-95
Download citation file:
Published: Ann Intern Med. 1991;114(1):95-96.
Hematology/Oncology, Lung Cancer, Pulmonary/Critical Care.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use